Download PDF
Drug Res (Stuttg) 2015; 65(08): 437-441
DOI: 10.1055/s-0034-1389949
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Comparison of the Effects of Methotrexate and Methylprednisolone in Spinal Cord Injury in Rats

H. Meng
1   Department of Bone and Joint Surgery, Shandong Jining First People’s Hospital, Jining City, Shandong Province, China
,
Y. Liu
2   Department of Endocrinology, Shandong Jining First People’s Hospital, Jining City, Shandong Province, China
,
K. Li
3   Department of Gynaecology and Obstetrics, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan City, Shandong Province, China
,
J. Li
1   Department of Bone and Joint Surgery, Shandong Jining First People’s Hospital, Jining City, Shandong Province, China
› Author Affiliations
Further Information

Publication History

received 05 July 2014

accepted 31 July 2014

Publication Date:
21 October 2014 (online)

Also available at
    Permissions and Reprints

Abstract

There are many biochemical and inflammatory reactions which develop due to the effect of secondary spinal cord injury (SCI) which is also called secondary cord damage. SCI can also create edema during acute stage. This study was designed to assess the probable protective effects of low-dose methotrexate and methylprednisolone in the spinal cord injury (SCI) in rats.

A total of 100 Wistar albino rats having weights in the range 250–350 g were used for this experiment. All the animals were divided into 5 groups. Laminectomy was performed in which SCI was induced using a temporary aneurysm clip. After clip compression, methotrexate and/or methylprednisolone was administered intraperitoneally. Control group is at 0 grades as there is no damage in the spinal cord tissue. MTX and MP treated groups are at grade 1 as they showed mild damage in spinal cord tissue. But the group 4 and group 5 also showed the grade 1 as they were treated with combination of both MTX and MP. Neither methotrexate nor methylprednisolone was shown to decrease the histopathological grade in either stage of SCI. Low-dose methotrexate was shown to decrease lipid peroxidation levels only in the sub-acute stage of SCI. Low dose methotrexate is more effective as compared to methylprednisolone in secondary spinal cord injury.

Key words

spinal cord injury - methotrexate - methylprednisolone - lipid peroxidation
 

  • References

  • 1 Bao F, Chen Y, Dekaban GA et al. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem 2004; 88: 1335-1344
    CrossrefPubMedGoogle Scholar
  • 2 Kaynar MY, Hanci M, Kafadar A et al. The effect of duration of compression on lipid peroxidation after experimental spinal cord injury. Neurosurg Rev 1998; 21: 117-120
    CrossrefPubMedGoogle Scholar
  • 3 Cronstein BN, Naime D, Ostad E. The anti-inflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993; 92: 2675-2682
    CrossrefPubMedGoogle Scholar
  • 4 Katchamart W, Trudeau J, Phumethum V et al. Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2009; 68: 1105-1112
    CrossrefPubMedGoogle Scholar
  • 5 Kaptanoglu E, Tuncel M, Palaoglu S et al. Comparison of the effects of melatonin and methylprednisolone in experimental spinal cord injury. J Neurosurg 2000; 93: 77-84
    CrossrefPubMedGoogle Scholar
  • 6 Chan ES, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002; 4: 266-273
    CrossrefPubMedGoogle Scholar
  • 7 Brcken MB, Shepard MJ, Hellenbrand KG et al. Methylprednisolone and neurological function 1 year after spinal cord injury. J Neurosurg 1985; 63: 704-713
    CrossrefPubMedGoogle Scholar
  • 8 Faden AI, Jacobs TP, Patrick DH et al. Megadose corticosteroid therapy following experimental traumatic spinal injury. J Neuerosurg 1984; 60: 712-717
    PubMedGoogle Scholar
  • 9 Hall ED. The neuroprotective pharmacology of methylprednisolone. J Neurosurg 1992; 76: 13-22
    CrossrefPubMedGoogle Scholar
  • 10 Means ED, Anderson DK, Waetrs TR et al. Effect of methylprednisolone in compression trauma to the feline spinal cord. J Neuerosurg 1981; 55: 200-208
    PubMedGoogle Scholar
  • 11 Braughler JM, Hall ED. Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism. J Nerosurg 1984; 61: 290-295
    PubMedGoogle Scholar
  • 12 Rivlin AS, Tator CH. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 1978; 10: 38-43
    PubMedGoogle Scholar
  • 13 Demirpençe E, Köksoy C, Kuzu A et al. A spectrophotometric assay for tissue associated myeloperoxidase activity and its application to intestinal ischemia-reperfusion. Turk J Med Sci 1997; 27: 197-200
    PubMedGoogle Scholar
  • 14 Suzuki K, Ota H, Sasagawa S et al. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983; 132: 345-352
    CrossrefPubMedGoogle Scholar
  • 15 Nie NH, Hull CH, Jenkins JG. SPSS: statistical package for social science. New York: McGraw Hill Inc; 1975
    Google Scholar
  • 16 Leskovar A, Moriarty LJ, Turek JJ et al. The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. J Exp Biol 2000; 203: 1783-1795
    PubMedGoogle Scholar
  • 17 Christie SD, Comeau B, Myers T et al. Duration of lipid peroxidation after acute spinal cord injury in rats and the effect of methylprednisolone. Neurosurg Focus 2008; 25: E5
    PubMedGoogle Scholar
  • 18 Bao F, Chen Y, Dekaban GA et al. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem 2004; 88: 1335-1344
    CrossrefPubMedGoogle Scholar
  • 19 Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14: 157-167
    CrossrefPubMedGoogle Scholar